Latest News
The S&P 500 Index ($SPX ) (SPY ) Wednesday closed up +0.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.16%. Stocks on Wednesday settled mixed. The overall market found support from the as-expected US...
1 Magnificent S&P 500 Dividend Stock Down 12% to Buy After Its Recent Pullback
Zoetis looks like a classic example of a premium business trading at a fair price following its recent dip.
3 Spectacular High-Yield Dividend Stocks to Buy in November
High yields aren't a warning indicator with these three stocks.
2 Magnificent S&P 500 Dividend Stocks Down Year to Date to Buy and Hold Forever
More than a few companies that did well in the past are out of favor with investors. And that could spell opportunity.
With Nvidia Kicking Intel Out of the Dow Jones, Will Meta Platforms or Alphabet Eventually Replace Walt Disney Stock?
The Dow Jones Industrial Average's shift away from value and income could open the door for other mega-cap growth stocks.
2 Healthcare Dividend Stocks That Are Screaming Buys in November
One stock yields 6% today. Another has grown its dividend by 460% over the past decade. Both are blue chip bargains to buy right now.
3 Reasons Pfizer Looks Like a No-Brainer Buy Right Now
Pfizer is trading above its 52-week low but is still a dirt cheap buy.
2 Magnificent Stocks to Buy That Are Near 52-Week Lows
These stocks near 52-week lows could be ready to rebound.
1 Green Flag That's Also a Red Flag for Pfizer Stock
An activist investor has correctly identified a dysfunctional area of the business.
This pharmaceutical giant's Q3 numbers came in ahead of Street estimates.
However, don’t expect big immediate gains
Is Pfizer Stock a Bargain for Long-Term Investors?
Wall Street's bearish take on this proven innovator may not be warranted.
2 Sensational Growth Stocks to Buy at a Discount
These growth stocks are looking especially attractive right now.
This Beaten-Down Stock Just Gave Investors More Good News: Is it a Buy?
Slowly but surely, the company's prospects are looking more attractive.
3 Potential Catalysts That Could Lift Pfizer Stock Before 2025
The pipeline could yield a winner, but so could a few organizational changes.
3 Reasons Relying on Social Security Alone Could be a Risk. And 3 Stocks to Invest in Today.
Social Security is likely to deliver less income than you expect. But you can make up the difference and more via dividend-paying stocks.
Comments come as Ottawa software company, which faces calls from some investors to sell, continues to generate sluggish sales growth
3 Factors That Make Pfizer's Ultra-High-Yield Dividend Safer Than You Might Think
Pfizer's dividends should keep flowing and growing.
This Big New Development Could Be Bullish for Kenvue Stock
Can tinkering around the edges actually make this stock more attractive?
Why Pfizer Stock Tumbled on Tuesday
The specter of an activist investor looms over the company.
Pfizer (PFE) Q3 2024 Earnings Call Transcript
PFE earnings call for the period ending September 30, 2024.
Pfizer’s Stock Gains On Earnings Beat And Raised Guidance
The stock of Pfizer (PFE) is up about 2% after the pharmaceutical company issued third-quarter financial ...
The S&P 500 Index ($SPX ) (SPY ) today is down -0.10%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.10%. Stocks today are narrowly mixed on caution ahead of a slew of key events,...
A boost from COVID-19 treatment sales helped bush Pfizer to a better-than-expected third quarter and higher forecast for the year
A survey of North American equities heading in both directions